(LYRA) – Momentum Movers
-
Lyra Therapeutics (LYRA) Up 13% Following Positive FDA Meeting
-
Lyra Therapeutics (LYRA), LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
Back to LYRA Stock Lookup